{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3157.4018","meta":{"versionId":"9","lastUpdated":"2019-02-16T01:00:02.000-05:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Fibrinolytic Therapy</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <a href=\"http://loinc.org\">\n            <code>http://loinc.org</code>\n          </a>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/21464-3.html\">21464-3</a>\n              </td>\n              <td>Plasminogen activator urokinase type [Presence] in Tissue</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/43636-0.html\">43636-0</a>\n              </td>\n              <td>Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic method</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/5971-7.html\">5971-7</a>\n              </td>\n              <td>Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/5972-5.html\">5972-5</a>\n              </td>\n              <td>Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/5973-3.html\">5973-3</a>\n              </td>\n              <td>Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/5981-6.html\">5981-6</a>\n              </td>\n              <td>Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/5982-4.html\">5982-4</a>\n              </td>\n              <td>Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/5983-2.html\">5983-2</a>\n              </td>\n              <td>Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/5986-5.html\">5986-5</a>\n              </td>\n              <td>Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/5987-3.html\">5987-3</a>\n              </td>\n              <td>Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/5988-1.html\">5988-1</a>\n              </td>\n              <td>Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/5989-9.html\">5989-9</a>\n              </td>\n              <td>Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/5990-7.html\">5990-7</a>\n              </td>\n              <td>Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/88659-8.html\">88659-8</a>\n              </td>\n              <td>Timing of thrombolytic administration in relation to cardiac arrest</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/LP131329-7.html\">LP131329-7</a>\n              </td>\n              <td>Plasminogen activator urokinase type | Tissue and Smears</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/LP16885-3.html\">LP16885-3</a>\n              </td>\n              <td>Plasminogen activator tissue type Ag</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/LP16889-5.html\">LP16889-5</a>\n              </td>\n              <td>Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/LP16891-1.html\">LP16891-1</a>\n              </td>\n              <td>Plasminogen activator tissue type</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/LP265990-4.html\">LP265990-4</a>\n              </td>\n              <td>Timing of thrombolytic administration in relation to cardiac arrest</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/LP52810-6.html\">LP52810-6</a>\n              </td>\n              <td>Plasminogen activator tissue type | platelet poor plasma</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://details.loinc.org/LOINC/LP70416-0.html\">LP70416-0</a>\n              </td>\n              <td>Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex | Platelet poor plasma</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3157.4018","version":"20190216","name":"Fibrinolytic Therapy","status":"active","date":"2019-02-16T01:00:02-05:00","publisher":"Lewin EH Steward","compose":{"include":[{"system":"http://loinc.org","concept":[{"code":"21464-3","display":"Plasminogen activator urokinase type [Presence] in Tissue"},{"code":"43636-0","display":"Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic method"},{"code":"5971-7","display":"Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay"},{"code":"5972-5","display":"Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis"},{"code":"5973-3","display":"Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis"},{"code":"5981-6","display":"Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay"},{"code":"5982-4","display":"Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis"},{"code":"5983-2","display":"Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis"},{"code":"5986-5","display":"Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method"},{"code":"5987-3","display":"Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method"},{"code":"5988-1","display":"Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis"},{"code":"5989-9","display":"Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasis"},{"code":"5990-7","display":"Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasis"},{"code":"88659-8","display":"Timing of thrombolytic administration in relation to cardiac arrest"},{"code":"LP131329-7","display":"Plasminogen activator urokinase type | Tissue and Smears"},{"code":"LP16885-3","display":"Plasminogen activator tissue type Ag"},{"code":"LP16889-5","display":"Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex"},{"code":"LP16891-1","display":"Plasminogen activator tissue type"},{"code":"LP265990-4","display":"Timing of thrombolytic administration in relation to cardiac arrest"},{"code":"LP52810-6","display":"Plasminogen activator tissue type | platelet poor plasma"},{"code":"LP70416-0","display":"Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex | Platelet poor plasma"}]}]}}